Impact of Tafamidis on Survival in a Real-World Community-Based Cohort-Reference-Cited by-同舟云学术

Impact of Tafamidis on Survival in a Real-World Community-Based Cohort

Published:2022-12 Issue:12 Volume:47 Page:101358
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Hussain Kifah^ORCID,Macrinici Victor,Wathen Lucas,Balasubramanian Senthil S.,Minga Iva,Gaznabi Safwan,Kwak Esther,Wang Chi-Hsiung,Iqbal Suha Haider,Pursnani Amit,Sarswat Nitasha

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference21 articles.

1. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy;Maurer;N Engl J Med,2018

2. Recent advances in the pharmacotherapy of TTR amyloidosis of the heart;Shah;Vessel Plus,2021

3. A systematic review of tafamidis in patients with transthyretin amyloid cardiomyopathy;Singh;Cureus,2021

4. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction;González-López;Eur Heart J,2015

5. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study;Tanskanen;Ann Med,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transthyretin Stabilizer Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis;American Journal of Therapeutics;2024-08-07

2. Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data;Journal of the American Heart Association;2024-07-16

3. Tafamidis therapy in transthyretin amyloid cardiomyopathy: a narrative review from clinical trials and real-world evidence;The Egyptian Heart Journal;2024-07-10

4. Response to therapy with tafamidis 61 mg in patients with cardiac transthyretin amyloidosis: real-world experience since approval;Amyloid;2024-07-02

5. Tafamidis in the Treatment of ATTR-related Cardiomyopathy;Heart Failure Clinics;2024-07